KIF11 and breast carcinoma: The representative tetrahydro-β-carboline analogs that have been discovered for their anti-tumor mechanism are as follows: inhibitors of mitotic kinesin Eg5 and inhibitors of breast cancer resistant ATP-binding cassette sub-family G member 2(ABCG2).